High-level expression, purification and characterization of codon-optimized recombinant hemagglutinin 5 proteins in mammalian cells

被引:3
作者
Yang Jing-lin [1 ,2 ]
Wang Hong-liang [1 ,2 ]
Wang Shun-xin [1 ,2 ]
Yang Peng [1 ,2 ]
Liu Kang-tai [1 ,2 ]
Jiang Cheng-yu [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Key Lab Med Mol Biol, Beijing 100005, Peoples R China
[2] Peking Union Med Coll, Beijing 100005, Peoples R China
基金
中国国家自然科学基金;
关键词
hemagglutinin; avian influenza; protein purification; mammalian cell expression; A VIRUS H5N1; AVIAN INFLUENZA; MEMBRANE-FUSION; VACCINE; GLYCOSYLATION; INFECTIONS; IMPACT; ENTRY;
D O I
10.3760/cma.j.issn.0366-6999.2010.08.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Numerous Asian cases of avian influenza virus infection, especially the highly pathogenic strain H5N1, in humans have raised the concern that another influenza pandemic is close. However, there are no effective therapeutic drugs or preventative vaccines available. Hemagglutinin is the membrane glycoprotein of avian influenza virus responsible for receptor binding to human cells and the main immunogenic protein that elicits a strong immune response. Although this protein is of great importance to the study of pathogenesis and vaccine development, its expression and purification are difficult due to high levels of glycosylation. Methods In this study, we expressed codon-optimized, full-length hemagglutinin 5 (H5) protein fused with a human IgG Fc tag (H5-Fc) in HEK293 cells. To enhance secretion of this protein, we also deleted the transmembrane domain and the intracellular domain of the H5 protein (H5 Delta TM-Fc). Purified proteins were obtained using a protein A column. Results ELISA revealed that the yield of soluble H5 Delta TM-Fc protein in the supernatant was about 20 mg/L. Western blotting and fluorescence activated cell sorter (FACS) indicated that the purified H5 protein was correctly folded and biologically active. Conclusion Purification of H5 proteins from mammalian cells could be used for large-scale production of recombinant H5 protein for basic scientific research or the development of vaccines. Chin Med J 2010;123(8):1073-1077
引用
收藏
页码:1073 / 1077
页数:5
相关论文
共 22 条
[12]   Seasonal influenza vaccination may mitigate the potential impact of an H5N1 pandemic [J].
Qin Cheng-feng ;
Qin E-de .
CHINESE MEDICAL JOURNAL, 2008, 121 (15) :1481-1483
[13]   Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin [J].
Skehel, JJ ;
Wiley, DC .
ANNUAL REVIEW OF BIOCHEMISTRY, 2000, 69 :531-569
[14]   A CARBOHYDRATE SIDE-CHAIN ON HEMAGGLUTININS OF HONG-KONG INFLUENZA-VIRUSES INHIBITS RECOGNITION BY A MONOCLONAL-ANTIBODY [J].
SKEHEL, JJ ;
STEVENS, DJ ;
DANIELS, RS ;
DOUGLAS, AR ;
KNOSSOW, M ;
WILSON, IA ;
WILEY, DC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (06) :1779-1783
[15]   Confronting the avian influenza threat: vaccine development for a potential pandemic [J].
Stephenson, I ;
Nicholson, KG ;
Wood, JM ;
Zambon, MC ;
Katz, JM .
LANCET INFECTIOUS DISEASES, 2004, 4 (08) :499-509
[16]  
Sugrue Richard J, 2007, Methods Mol Biol, V379, P1
[17]   Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells [J].
Throsby, Mark ;
van den Brink, Edward ;
Jongeneelen, Mandy ;
Poon, Leo L. M. ;
Alard, Philippe ;
Cornelissen, Lisette ;
Bakker, Arjen ;
Cox, Freek ;
van Deventer, Els ;
Guan, Yi ;
Cinatl, Jindrich ;
ter Meulen, Jan ;
Lasters, Ignace ;
Carsetti, Rita ;
Peiris, Malik ;
de Kruif, John ;
Goudsmit, Jaap .
PLOS ONE, 2008, 3 (12)
[18]   Avian influenza H5N1: an update on molecular pathogenesis [J].
Wang HongLiang ;
Jiang ChengYu .
SCIENCE IN CHINA SERIES C-LIFE SCIENCES, 2009, 52 (05) :459-463
[19]   Influenza A virus H5N1 entry into host cells is through clathrin-dependent endocytosis [J].
Wang HongLiang ;
Jiang ChengYu .
SCIENCE IN CHINA SERIES C-LIFE SCIENCES, 2009, 52 (05) :464-469
[20]   Expression and purification of an influenza hemagglutinin - one step closer to a recombinant protein-based influenza vaccine [J].
Wang, K ;
Holtz, KM ;
Anderson, K ;
Chubet, R ;
Mahmoud, W ;
Cox, MMJ .
VACCINE, 2006, 24 (12) :2176-2185